Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Vilin Bio Med Limited (NSE: VILINBIO), ISIN INE0L4V01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VILINBIO last traded at ₹52.30 (-4.91%), with a 52-week range of ₹18.95 to ₹60.95 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 56.65%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.